T1	Participants 526 600	467 women with type 1 or 2 endometrial cancer and 582 age-matched controls
T2	Participants 694 771	46 women with type 1 endometrial cancer enrolled in RTOG trials 9708 and 9905
T3	Participants 1319 1366	patients with the variant and wild-type alleles
#1	AnnotatorNotes T3	maybe...
